Navin Fluorine International Limited (NAVINFLUOR)

Loading page…

Navin Fluorine International Limited (NAVINFLUOR) · mywealthgrid

About

Navin Fluorine produces specialty chemicals in the fluorine segment for pharmaceuticals, refrigerants, and advanced materials. At ₹42,245.55 Cr market cap, operating margins of 32–35%, and ROE of 20.11%, it demonstrates strong profitability and efficient capital deployment.

Face value: ₹2

Market cap

₹41,740 Cr

P/E

52.9×

P/B

10.5×

Dividend yield

0.3%

ROE

20.1%

ROCE

21.6%

Debt / equity

0.31

OPM

32.6%

EPS (TTM)

₹154.1

Book value

₹775.5

52-week high

—

52-week low

Key insights

Company research notes and source-linked reviews

Key risks

Valuation: PE 53.5 is elevated for specialty chemicals; verify sustainable earnings-growth rate
Margin exposure: quarterly OPM ranges 28–35%, indicating input-cost or product-mix sensitivity
Customer concentration: typical in specialty chemicals; audit revenue dependency on top customers
Raw-material volatility: fluorine feedstock costs could compress margins; verify hedging mechanisms

Generated analysis · source review pending

Growth drivers

Earnings expansion: EPS grew from ₹20.66 (Dec 2025) to ₹47.45 (Jun 2026) on revenue growth amid stable 28–35% OPM
Capital headroom: D/E 0.31 and ROE 20.11% indicate balance-sheet capacity for growth investment; verify capex pipeline
Operating resilience: sustained 28–35% OPM suggests pricing power or cost control; verify which mechanism
Served markets: company addresses pharma, refrigerants, advanced materials; verify growth rates per segment

Generated analysis · source review pending

2,528 historical price candles were omitted because the exchange source has not been verified.

₹8,136.5-1.2%1Y

Quick read

rule-based

Pros

+Healthy operating margin of 32.6%
+Profit CAGR of 20.8% over the last 5 years
+Revenue CAGR of 23% over the last 5 years

Cons

−Trading at 10.5× book value

Research score

Structured signal from quality, growth, valuation and momentum.

54/100

Business quality: 69
Growth: 84
Valuation: 9

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Part ofNIFTY SMALLCAP 50 NIFTY SMALLCAP 100 NIFTY SMALLCAP 250 NIFTY MIDSMALLCAP 400 NIFTY 500

Screen this industry

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	783	925	996	1,062	1,179	1,453	2,077	2,065	2,349	3,314
COGS	327	402	477	484	537	666	896	935	1,039	1,376
Gross profit	456	523	519	578	642	788	1,181	1,130	1,311	1,938
	297	308	301	307	322	433	631	731	777	856
	159	215	218	271	320	355	550	398	534	1,082
OPM %	20.3%	23.2%	21.9%	25.5%	27.1%	24.4%	26.5%	19.3%	22.7%	32.6%
Depreciation	30	40	28	37	44	48	63	96	119	149
Interest	3	1	1	2	2	2	28	75	78	118
	56	93	34	33	95	39	36	108	44	59
Profit before tax	182	266	224	265	368	344	496	336	380	873
Tax	45	84	77	-144	111	81	121	65	91	210
Tax %	24.8%	31.5%	34.3%	-54.2%	30.1%	23.6%	24.3%	19.4%	24.1%	24%
	137	182	147	409	258	263	375	271	289	664
PAT margin %	17.5%	19.7%	14.8%	38.5%	21.8%	18.1%	18.1%	13.1%	12.3%	20%
EPS (₹)	—	—	—	82.6	52	53.1	75.7	54.6	58.2	130.7
EPS adjusted (₹)	27.9	36.4	30.2	82.5	52	53.1	75.7	54.6	58.2	129.5
	—	—	—	13.3%	21.1%	20.7%	19.8%	22%	20.6%	11.6%
Annual report	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	Annual report for Mar 2026

₹ Cr	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	10	10	10	10	10	10	10	10	10	10
Reserves	721	974	1,063	1,402	1,624	1,834	2,175	2,373	2,616	3,964
	52	13	4	1	3	104	849	1,340	1,441	1,226
	198	259	231	215	261	437	496	654	763	1,178
Total equity & liabilities	981	1,256	1,307	1,629	1,898	2,385	3,529	4,377	4,830	6,379
	361	370	374	453	442	466	1,594	1,824	2,687	3,275
CWIP	14	20	39	39	95	742	279	711	350	143
Investments	222	428	427	195	153	171	95	545	529	1,277
	383	437	466	941	1,207	1,007	1,561	1,296	1,264	1,683
Total assets	981	1,256	1,307	1,629	1,898	2,385	3,529	4,377	4,830	6,379

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	52.1%	54.4%	54.4%	54.2%	56.9%	54.7%	55.8%	58.5%
EBITDA margin %	21.9%	24.8%	26.2%	24.4%	26.5%	19.3%	22.7%	32.6%
EBIT margin %	19.2%	21.3%	22.5%	21.1%	23.5%	14.6%	17.6%	28.1%
PAT margin %	14.8%	38.5%	21.8%	18.1%	18.1%	13.1%	12.3%	20%
Working capital
Receivable days	63	75	88	90	99	91	90	83
Inventory days	86	119	122	141	191	145	113	118
Payable days	5	7	73	80	99	118	115	140
NWC days	144	188	137	151	190	118	89	61
Leverage
Current ratio	3.17	4.39	5.91	2.65	2.81	1.81	1.74	2.61
Debt to EBITDA	0.02	0.01	0.01	0.29	1.54	3.36	2.7	1.13
Debt to equity	0	0	0	0.06	0.39	0.56	0.55	0.31
Interest coverage	271.4	129.9	187	182.2	19	4.8	5.9	8.5
Asset turnover	0.76	0.65	0.62	0.61	0.59	0.47	0.49	0.52
Return ratios
Return on assets %	11.3%	25.1%	13.6%	11%	10.6%	6.2%	6%	10.4%
Return on capital employed %	20.7%	20.1%	21.9%	18.7%	20.9%	11%	12.3%	21.6%
Return on equity %	13.7%	28.9%	15.8%	14.3%	17.2%	11.4%	11%	16.7%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	28.81%	28.81%	28.81%	28.8%	28.44%	28.44%	28.44%	28.01%	27.12%	27.11%	27.11%	27.08%
	19.2%	15.92%	15.57%	18.02%	18.23%	18.55%	20.16%	21.55%	22.15%	23.74%	23.78%	23.73%
	26.02%	28.92%	28.61%	27.41%	28.18%	28.46%	30.04%	28.71%	29.57%	28.09%	27.62%	28.46%
	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	25.97%	26.35%	27.01%	25.77%	25.15%	24.55%	21.36%	21.73%	21.16%	21.06%	21.49%	20.73%
No. of shareholders	—	—	—	—	—	—	—	—	1,37,981	1,37,798	1,43,987	1,38,594

Promoter holding down 1.73 percentage points since Sep 2023.

3 disclosures

Person	Deal	Shares	Value	Holding	Filed
Mr. Rajendra Kumar SahuEmployees/Designated Employees	BuyESOP	3,250	₹1.08 cr	0.00% → 0.00%	23 Sept 20257(2)
Mr. Rajendra Kumar SahuEmployees/Designated Employees	BuyESOP	5,000	₹1.66 cr

37 deals · 11 Aug 2021 – 14 May 2025

Date	Client	Type	Venue	Side	Quantity	Price	Value
14 May 2025	VISHAD PADMANABH MAFATLAL	Block	NSE	Sell	2,10,000	₹4,287.00	₹90.03 Cr
14 May 2025	SBI MUTUAL FUND	Block	NSE	Buy	2,10,000	₹4,287.00	₹90.03 Cr
31 Jan 2025	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Buy	2,51,882	₹4,206.05	₹105.94 Cr
31 Jan 2025	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Sell	2,32,632	₹4,207.70	₹97.88 Cr
9 Jan 2025	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Buy	3,82,418	₹3,861.87	₹147.68 Cr
9 Jan 2025	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Sell	3,68,243	₹3,869.48	₹142.49 Cr
7 Feb 2024	SMALLCAP WORLD FUND INC	Bulk	NSE	Sell	5,10,449	₹3,099.70	₹158.22 Cr
7 Feb 2024	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Sell	2,53,742	₹3,094.37	₹78.52 Cr
7 Feb 2024	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Buy	2,53,742	₹3,104.53	₹78.77 Cr
14 Nov 2022	ISHARES CORE MSCI EMERGING MARKETS ETF	Block	NSE	Buy	36,252	₹4,459.55	₹16.17 Cr

1–10 of 37

1 / 4

Mr. Vishad Padmanabh MafatlalExecutive Director-Chairperson related to Promoter
Mr. Sunilbhai Siddharthbhai LalbhaiNon-Executive - Non Independent Director
Mr. Atul Kumar SrivastavaNon-Executive - Independent Director
Mr. Ashok SinhaNon-Executive - Independent Director
Mr. Sujal Anil ShahNon-Executive - Independent Director
Mrs. Apurva PurohitNon-Executive - Independent Director
Mr. Sudhir Ramchandra DeoNon-Executive - Non Independent Director
Mr. Abhijit Jagdish JoshiNon-Executive - Independent Director
Mr. Nitin Ganpati KulkarniExecutive Director-MD
Mr. Kartikeya DubeNon-Executive - Independent Director
Mr. Anish P. GanatraChief Financial Officer

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

Portfolio month

Schemes holding

124

across 18 fund houses

Held by these funds

13.89%

of the company's equity

All mutual funds

21.02%

shareholding pattern, Jun 2026

Portfolios as of

August 2026

compared with July 2026

124 schemes · 18 fund houses

		Shares
Smallcap Fund	SBI Mutual Fund	16.32 L	1,415.66	3.32%	3.181%	-0
SMALL CAP FUND	Nippon India Mutual Fund	5.67 L	492.22	0.6%	1.106%	-0
Small Cap Fund	Axis Mutual Fund	5.23 L	453.42	1.44%	1.019%	-0
ELSS- Tax Saver Fund	Axis Mutual Fund	4.13 L	358.59	1.1%	0.806%	+36,432
MultiCap Fund	SBI Mutual Fund	3 L	260.27	1.06%	0.585%	-0
MNC Fund	SBI Mutual Fund	2.8 L	242.91	3.62%	0.546%	-0
Small Cap Fund	DSP Mutual Fund	2.61 L	226.74	1.05%	0.509%	-0
Flexi Cap Fund	Axis Mutual Fund	2.5 L	217.22	1.56%	0.488%	+5,778

1–8 of 124

1 / 16

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

26 announcementsExport CSV

30 Sept 2026, 5:42 pmCompany Update

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Analyst / Investor Meet PDF

Loading announcements…

Ratio	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	52.1%	54.4%	54.4%	54.2%	56.9%	54.7%	55.8%	58.5%
EBITDA margin %	21.9%	24.8%	26.2%	24.4%	26.5%	19.3%	22.7%	32.6%
EBIT margin %	19.2%	21.3%	22.5%	21.1%	23.5%	14.6%	17.6%	28.1%
PAT margin %	14.8%	38.5%	21.8%	18.1%	18.1%	13.1%	12.3%	20%
Working capital
Receivable days	63	75	88	90	99	91	90	83
Inventory days	86	119	122	141	191	145	113	118
Payable days	5	7	73	80	99	118	115	140
NWC days	144	188	137	151	190	118	89	61
Leverage
Current ratio	3.17	4.39	5.91	2.65	2.81	1.81	1.74	2.61
Debt to EBITDA	0.02	0.01	0.01	0.29	1.54	3.36	2.7	1.13
Debt to equity	0	0	0	0.06	0.39	0.56	0.55	0.31
Interest coverage	271.4	129.9	187	182.2	19	4.8	5.9	8.5
Asset turnover	0.76	0.65	0.62	0.61	0.59	0.47	0.49	0.52
Return ratios
Return on assets %	11.3%	25.1%	13.6%	11%	10.6%	6.2%	6%	10.4%
Return on capital employed %	20.7%	20.1%	21.9%	18.7%	20.9%	11%	12.3%	21.6%
Return on equity %	13.7%	28.9%	15.8%	14.3%	17.2%	11.4%	11%	16.7%

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Gujarat Fluorochemicals LimitedFLUOROCHEMFLUOROCHEM	₹47,713 Cr	₹49,912 Cr	₹5,303 Cr	₹1,375 Cr	25.8%	₹615 Cr	11.5%	11.1%	7.6%	401
Navin Fluorine International LimitedNAVINFLUORNAVINFLUOR	₹41,740 Cr	₹42,967 Cr	₹3,634 Cr	₹1,232 Cr	32.6%	₹790 Cr	20%	21.6%	20.1%	61
Aether Industries LimitedAETHERAETHER	₹22,161 Cr	₹22,603 Cr	₹1,224 Cr	₹384 Cr	31.3%	₹235 Cr	19.8%	13.2%	9.4%	330
Atul LimitedATULATUL	₹17,231 Cr	₹17,411 Cr	₹6,643 Cr	₹1,189 Cr	16.4%	₹704 Cr	11%	14.1%	11.5%	70
Aarti Industries LimitedAARTIINDAARTIIND	₹16,869 Cr	₹21,790 Cr	₹9,012 Cr	₹1,337 Cr	14.1%	₹531 Cr	5.1%	8.8%	7.3%	54
Fine Organic Industries LimitedFINEORGFINEORG	₹15,752 Cr	₹15,797 Cr	₹2,472 Cr	₹535 Cr	20.4%	₹438 Cr	17.6%	21.6%	16.8%	113
Basf India LimitedBASFBASF	₹14,796 Cr	₹14,796 Cr	₹16,177 Cr	₹952 Cr	4.4%	₹643 Cr	2.8%	14%	11.1%	40
Privi Speciality Chemicals LimitedPRIVISCLPRIVISCL	₹13,970 Cr	₹14,980 Cr	₹2,671 Cr	₹666 Cr	25.2%	₹342 Cr	12.4%	27.7%	25.2%	158
Sudeep Pharma LimitedSUDEEPPHRMSUDEEPPHRM	₹13,546 Cr	₹13,694 Cr	₹676 Cr	₹233 Cr	34.6%	₹133 Cr	27.1%	31.1%	25.2%	366
Anupam Rasayan India LimitedANURASANURAS	₹13,243 Cr	₹15,058 Cr	₹2,535 Cr	₹563 Cr	22.2%	₹175 Cr	9.4%	9.1%	5.5%	377
Vinati Organics LimitedVINATIORGAVINATIORGA	₹12,528 Cr	₹12,528 Cr	₹2,381 Cr	₹665 Cr	29.4%	₹448 Cr	19.9%	18.8%	14.9%	152
Elantas Beck India LimitedELANTASELANTAS	₹10,644 Cr	₹10,644 Cr	₹778 Cr	₹147 Cr	20.3%	₹136 Cr	17.4%	20.6%	15.8%	70

Date	Category	Subject	Filing
30 Sept 2026, 5:42 pm	Company Update Analyst / Investor Meet	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation	PDF
29 Sept 2026, 3:19 pm	Company Update General	Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Update On Debottlenecking Of Multi Purpose Plant Facility At Dahej Site	PDF
16 Sept 2026, 11:59 am	Company Update Credit Rating	Announcement under Regulation 30 (LODR)-Credit Rating	PDF
9 Sept 2026, 11:42 am	Company Update Newspaper Publication	Announcement under Regulation 30 (LODR)-Newspaper Publication	PDF
7 Sept 2026, 12:52 pm	Company Update Analyst / Investor Meet	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation	PDF
7 Sept 2026, 12:50 pm	Company Update Analyst / Investor Meet	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation	PDF
26 Aug 2026, 6:09 pm	Company Update Allotment of ESOP / ESPS	Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS	PDF
18 Aug 2026, 5:57 pm	Company Update Credit Rating	Announcement under Regulation 30 (LODR)-Credit Rating	PDF

₹ Cr	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	92	169	90	157	237	75	-64	750	571	894
	-16	-136	-24	85	-237	-172	-656	-1,093	-511	-1,235
	-67	-39	-68	-81	-45	42	658	336	-47	344
Net cash flow	10	-6	-3	161	-45	-56	-61	-8	13	3
Free cash flow	—	—	—	—	139	-504	-821	18	10	408
CFO / Operating profit %	58.2%	78.8%	41.3%	59.5%	76.7%	21.1%	-11.6%	188.3%	107%	82.6%

Navin Fluorine International Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Events

Announcements

Not in the F&O segment

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

1

42

2

Compounded sales growth

Compounded profit growth

Return on equity

Navin Fluorine International Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Ratios

Ratio timeline

Shareholding

Quarterly record

Insider dealing

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Events

Announcements

Ratio timeline

Not in the F&O segment

Quarterly record

Insider dealing

Bulk & block deals

Board and management

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

Upcoming and recent1

Dividends42

Board meetings2

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

1

42

2